CORRESP Filing
Jyong Biotech Ltd.
Date: June 12, 2025 · CIK: 0001954488 · Accession: 0001213900-25-053878
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-277725
Letter
Jyong Biotech Ltd.
23F-3, No. 95, Section 1, Xintai 5th Road
Xizhi District, New Taipei City
Taiwan, 221
June 12, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Doris Stacey Gama/ Ms. Suzanne Hayes
Re: Jyong Biotech Ltd.
Post-Effective Amendment No. 2 to Registration Statement on Form F-1
File No. 333-277725
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Act "), Jyong Biotech Ltd. (the " Company ") respectfully requests that the effective date of the registration statement referred to above (the " Registration Statement ") be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Monday, June 16, 2025, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Sichenzia Ross Ference Carmel LLP by calling Shane Wu, Esq. at (202) 322-8852. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Sichenzia Ross Ference Carmel LLP, Attention: Shane Wu, Esq, by email at swu@srfc.law and Tomer Magid, by email at tmagid@srfc.law .
If you have any questions regarding this request, please contact Shane Wu, Esq. of Sichenzia Ross Ference Carmel LLP, at (202) 322-8852.
Very Truly Yours,
By:
/s/ Fu-Feng Kuo
Show Raw Text
CORRESP 1 filename1.htm Jyong Biotech Ltd. 23F-3, No. 95, Section 1, Xintai 5th Road Xizhi District, New Taipei City Taiwan, 221 June 12, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Doris Stacey Gama/ Ms. Suzanne Hayes Re: Jyong Biotech Ltd. Post-Effective Amendment No. 2 to Registration Statement on Form F-1 File No. 333-277725 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Act "), Jyong Biotech Ltd. (the " Company ") respectfully requests that the effective date of the registration statement referred to above (the " Registration Statement ") be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Monday, June 16, 2025, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Sichenzia Ross Ference Carmel LLP by calling Shane Wu, Esq. at (202) 322-8852. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Sichenzia Ross Ference Carmel LLP, Attention: Shane Wu, Esq, by email at swu@srfc.law and Tomer Magid, by email at tmagid@srfc.law . If you have any questions regarding this request, please contact Shane Wu, Esq. of Sichenzia Ross Ference Carmel LLP, at (202) 322-8852. Very Truly Yours, By: /s/ Fu-Feng Kuo Name: Fu-Feng Kuo Title: Chief Executive Officer cc: Shane Wu, Esq. of Sichenzia Ross Ference Carmel LLP